CARDIOEMBOLIC STROKE ASSOCIATED WITH NONVALVULAR ATRIAL FIBRILLATION

This article examines current aspects of cardioembolic stroke (CES) as an acute cerebrovascular accident, focusing on its epidemiology, etiopathogenesis, and clinical manifestations. Statistical data on stroke incidence and mortality are presented, highlighting significant regional differences, with a particularly high incidence in Eastern Europe and Russia. It is noted that stroke has traditionally been perceived as a problem of the elderly; however, in recent decades, an increase in cases has been recorded among young people, due to the increasing prevalence of cardiovascular risk factors and improved diagnostic methods. Furthermore, the article examines in detail the relationship between atrial fibrillation and the development of CES, and describes the mechanisms leading to ischemic stroke, including embolization. The economic consequences of stroke, such as disability and the high cost of rehabilitation, are discussed, which negatively impact the social and economic aspects of society. In conclusion, the need for early diagnosis, effective treatment and rehabilitation of patients, as well as the implementation of a comprehensive approach to stroke management, is noted in order to reduce disability and improve quality of life.

1. Pawluk H., Woźniak A., Grześk G., et al. The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke. Dove Press journal: Clinical Interventions in Aging. 2022. 15. 489-484. DOI: 10.2147/CIA.S233909.

2. Atamanov S.A., Melnik A.V., Kvashin A.I., Korobeynikov I.V., Grigoriev E.G. Emergency X-ray endovascular thromboaspiration in cardioembolic ischemic stroke. Bulletin of Siberian Medicine. 2020. 19 (3). 198-203. In Russian.

3. Neurology: national guidelines: in 2 volumes / edited by E.I. Gusev, A.N. Konovalov, V.I. Skvortsova. M. GEOTAR-Media, 2019. 880. In Russian.

4. Ryabchenko A.Yu., Dolgov A.M., Denisov E.N., et al. Markers of endothelial dysfunction in ischemic stroke, depending on its pathogenetic subtypes. <url>. Neurology and Psychiatry. 2016. 4. 22-25. In Russian.

5. Nikishin V.O., Golokhvastov S.Yu., Litvinenko I.V., et al. Ischemic stroke in young people. Risk factors, features of etiopathogenesis. Bulletin of the Russian Military Medical Academy. 2020. DOI: 10.32863/1682-7392-2020-3-71-68-71. In Russian.

6. Clinical guidelines for atrial fibrillation and flutter in adults in 2020. http://disuria.ru/_ld/11/1114_kr20I48MZ.pdf. In Russian.

7. Yaghi S. Diagnosis and Management of Cardioembolic Stroke. Continuum (Minneap Minn). 2023. DOI: 10.1212/CON.0000000000001217.

8. Kobayashi S. (Ed.) Stroke Data Bank. Nakayama Shoten. 2015. 6.

9. Damulin I.V., Andreev D.A., Salpagarova Z.K. Cardioembolic stroke. Neurology, neuropsychiatry, psychosomatics. 2015. In Russian.

10. Sanna T., Diener H.C., Passman R.S., et al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 2014.

11. Tatarskiy B.A., Napalkov D.A. Atrial fibrillation: a marker or risk factor for stroke. Rational Pharmacotherapy in Cardiology. 2023. DOI: 10.20996/1819-6446-2023-01-06.

12. Di Carlo Bellino L., Zaninell F., Baldereschi A. Fibrillazione Atriale in Italia. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019. 21 (10). 1468–1475. DOI: 10.1093/europace/euz141. In Russian.

13. Chugh S.S., Havmoeller R., Narayanan K. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014. 8. 837–847. DOI: 10.1161/CIRCULATIONAHA.113.005119.

14. Lukyanov M.M., Gromova T.A., Martsevich S.Yu., et al. Patients with atrial fibrillation after discharge from a multidisciplinary hospital: an analysis of the risk of death and its causes based on 10 years of follow-up. Cardiovascular therapy and prevention. 2024. DOI: 10.15829/1728-8800-2024-4263. In Russian.

15. Yu M.Y., Caprio F.Z., Bernstein R.A. Cardioembolic Stroke. Neurol Clin. 2024. DOI: 10.1016/j.ncl.2024.03.002.

16. Kamel H., Healey J.S. Cardioembolic Stroke. Circ Res. 2017. 3. DOI: 10.1161/CIRCRESAHA.116.308407.

17. Sporns P.B. Hanning, U. Schwindt W., et al. Ischemic Stroke: What Does the Histological Composition Tell Us About the Origin of the Thrombus? Stroke. 2017. 48. 2206–2209. DOI: 10.1161/STROKEAHA.117.016590.

18. Feng D., D'Agostino R.B., Silbershatz H., et al. Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol. 2001. 87. DOI: 10.1016/s0002-9149(00)01310-2.

19. Korobchenko E.E. The state of the hemostasis system in patients with various forms of atrial fibrillation [abstract of the dissertation for the degree of Candidate of Medical Sciences]. Chelyabinsk. South Ural State Medical University. 2013.

20. Ibragimova G.Z., Sabirova A.R., Bilalova R.R., Akhtareev R. Risk factors for ischemic cardioembolic stroke. Bulletin of modern Clinical Medicine. 2019. In Russian.

21. Tsivgoulis G., Katsanos A.H., Sandset E.C. [et al.]. Thrombolysis for acute ischaemic stroke: current status and future perspectives. The Lancet Neurology. 22 (5). DOI: 10.1016/S1474-4422(22)00519-1.

22. Novikova L.B., Hakobyan A.P., Sharapova K.M., et al. Reperfusion therapy of ischemic stroke. Cardiovascular therapy and prevention. 2020. DOI: 10.15829/1728-8800-2019-2192. In Rusian.

23. Protocol of thrombolytic therapy of ischemic stroke. First Saint Petersburg State Medical University named after Academician I.P. Pavlov. St. Petersburg. 2023. In Russian.

24. Ornello R., Degan D., Tiseo C. [et al.]. Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes. Stroke. 2018. DOI:10.1161/strokeaha.117.020031.

25. Salova E.A., Krasnoshchekova L.I., Tochenov M.Yu. et al. The state of the hemostasis system in the acute period of ischemic stroke, taking into account its heterogeneity. 2012. DOI: 10.1161/STROKEAHA.120.032810. In Russian.

26. Ibragimova G.Z., Sabirova A.R., Bilalova R.R., Akhtereev R.N. Risk factors for ischemic cardioembolic stroke. Bulletin of Modern Clinical Medicine. 2019. 12 (5). 20–24. DOI: 10.20969/VSKM. In Russian.

27. Lindsherg PJ. ICAM-1 as a potential target for treatments blocking the host response in stroke. Keio J Med. 1996. 45. 44–51.

28. Simundic A.M, Basic V., Topic E., et al. Soluble adhesion molecules in acute ischemic stroke. Clin Invest Med. 2004. 27. 87–92.

29. Kaplanski G., Marin V., Fabrigoule M., et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood. 1998. 92. 59–67.

30. Takahashi M., Ikeda U., Masuyama J., et al. Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. Cardiovasc Res. 1996. 32. 2–9. DOI: 10.1016/0008-6363(96)00085-5.